Transplant-Ineligible Symptomatic but Indolent Multiple Myeloma Shows Better Prognosis with Conventional Agents

Transplant-Ineligible Symptomatic but Indolent Multiple Myeloma Shows Better Prognosis with Conventional Agents

The survival of multiple myeloma patients has improved significantly over the last several decades. However, the median overall survival of these patients remains less than 5 years. In this report, we discuss 4 cases of multiple myeloma patients that showed long survival. Interestingly, these patien...

Full description

Bibliographic Details
Main Authors: Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma, Yukie Tsubokura, Akiko Konishi, Masaaki Hotta, Hideaki Yoshimura, Kazuyoshi Ishii, Tomoki Ito, Shosaku Nomura
Format: Article
Language:English
Published: Karger Publishers 2017-10-01
Series:Case Reports in Oncology
Subjects:
Indolent
Symptomatic myeloma
Conventional therapy
Absence of deep response
Online Access:https://www.karger.com/Article/FullText/481166

Internet

https://www.karger.com/Article/FullText/481166

Similar Items